Home > Insider Trading > Filing (0001213900-18-010085)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1513525	Adial Pharmaceuticals Inc.	ADIL	Pharmaceutical Preparations (2834)	800667150

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1717971	Tony Goodman	1180 Seminole Trail, Suite 495 Charlottesville, VA 22901		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-07-31	7,000	$0.00	8,755	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to purchase common stock	Acquisiton	2018-07-31	7,000	$0.00	7,000	$6.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
7,000	2018-07-31	2023-07-31	No	4	P	Direct

Footnotes

On July 31, 2018, the reporting person purchased 7,000 units (the "Units") in the initial public offering (the "IPO") of Adial Pharmaceuticals, Inc. (the "Company") at a price of $5.00 per Unit, which corresponds to a price of $4.99 per share of common stock and $0.01 per warrant). Each Unit consisted of one share of common stock and a warrant to purchase one share of common stock. The shares of common stock and warrants were immediately separable upon issuance of the Units in the IPO.